Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000432481> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2000432481 endingPage "1470" @default.
- W2000432481 startingPage "1466" @default.
- W2000432481 abstract "Thirty patients with advanced non-small cell lung cancer (NSCLC) were treated with cisplatin (P), mitomycin C (M), and 5-fluorouracil (5-FU) chemotherapy. Twelve patients (40%) achieved major responses to therapy (11 partial, one regression). The median duration of partial response was 20 weeks. Median survival for the entire group was 29 weeks. Toxicity with this combination was moderate, with myelosuppression being the most significant toxic effect. Acute hematologic toxicity was generally mild, with 74% of patients having a leukocyte nadir greater than or equal to 2000/microliter and 67% with a platelet count nadir of greater than or equal to 100,000/microliter. There were, however, two toxic deaths during periods of treatment-induced cytopenia, 40% of patients developed significant anemia necessitating blood transfusions, and 33% had episodes of prolonged neutropenia. Nonhematologic toxicities were generally mild, although one patient developed a cardiac arrest of unclear etiology during day 4 of cycle 3 of treatment and died, for a total treatment mortality rate of 10% (three of 30). This drug combination produced a response rate comparable to those noted with other two or three drug cisplatin-based regimens in NSCLC but does not appear to offer any substantial advantage given its moderate toxicity, short duration of response, and necessity for substantial hospitalization." @default.
- W2000432481 created "2016-06-24" @default.
- W2000432481 creator A5003765000 @default.
- W2000432481 creator A5004853334 @default.
- W2000432481 creator A5037398995 @default.
- W2000432481 creator A5046702124 @default.
- W2000432481 creator A5080862046 @default.
- W2000432481 date "1988-10-15" @default.
- W2000432481 modified "2023-09-23" @default.
- W2000432481 title "Treatment of advanced non-small cell lung cancer with cisplatin, 5-fluorouracil, and mitomycin C" @default.
- W2000432481 cites W1856648916 @default.
- W2000432481 cites W1972728216 @default.
- W2000432481 cites W2059563719 @default.
- W2000432481 cites W2060717052 @default.
- W2000432481 cites W2084803292 @default.
- W2000432481 cites W2146505874 @default.
- W2000432481 cites W2212101069 @default.
- W2000432481 cites W2242162861 @default.
- W2000432481 cites W2262696150 @default.
- W2000432481 cites W2291356857 @default.
- W2000432481 doi "https://doi.org/10.1002/1097-0142(19881015)62:8<1466::aid-cncr2820620803>3.0.co;2-#" @default.
- W2000432481 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2844381" @default.
- W2000432481 hasPublicationYear "1988" @default.
- W2000432481 type Work @default.
- W2000432481 sameAs 2000432481 @default.
- W2000432481 citedByCount "5" @default.
- W2000432481 countsByYear W20004324812018 @default.
- W2000432481 crossrefType "journal-article" @default.
- W2000432481 hasAuthorship W2000432481A5003765000 @default.
- W2000432481 hasAuthorship W2000432481A5004853334 @default.
- W2000432481 hasAuthorship W2000432481A5037398995 @default.
- W2000432481 hasAuthorship W2000432481A5046702124 @default.
- W2000432481 hasAuthorship W2000432481A5080862046 @default.
- W2000432481 hasConcept C126322002 @default.
- W2000432481 hasConcept C141071460 @default.
- W2000432481 hasConcept C2776256026 @default.
- W2000432481 hasConcept C2776694085 @default.
- W2000432481 hasConcept C2777063308 @default.
- W2000432481 hasConcept C2778239845 @default.
- W2000432481 hasConcept C2778248108 @default.
- W2000432481 hasConcept C2779338040 @default.
- W2000432481 hasConcept C2780007613 @default.
- W2000432481 hasConcept C2780366003 @default.
- W2000432481 hasConcept C29730261 @default.
- W2000432481 hasConcept C71924100 @default.
- W2000432481 hasConcept C90924648 @default.
- W2000432481 hasConceptScore W2000432481C126322002 @default.
- W2000432481 hasConceptScore W2000432481C141071460 @default.
- W2000432481 hasConceptScore W2000432481C2776256026 @default.
- W2000432481 hasConceptScore W2000432481C2776694085 @default.
- W2000432481 hasConceptScore W2000432481C2777063308 @default.
- W2000432481 hasConceptScore W2000432481C2778239845 @default.
- W2000432481 hasConceptScore W2000432481C2778248108 @default.
- W2000432481 hasConceptScore W2000432481C2779338040 @default.
- W2000432481 hasConceptScore W2000432481C2780007613 @default.
- W2000432481 hasConceptScore W2000432481C2780366003 @default.
- W2000432481 hasConceptScore W2000432481C29730261 @default.
- W2000432481 hasConceptScore W2000432481C71924100 @default.
- W2000432481 hasConceptScore W2000432481C90924648 @default.
- W2000432481 hasIssue "8" @default.
- W2000432481 hasLocation W20004324811 @default.
- W2000432481 hasLocation W20004324812 @default.
- W2000432481 hasOpenAccess W2000432481 @default.
- W2000432481 hasPrimaryLocation W20004324811 @default.
- W2000432481 hasRelatedWork W1484554393 @default.
- W2000432481 hasRelatedWork W2058846783 @default.
- W2000432481 hasRelatedWork W2085562186 @default.
- W2000432481 hasRelatedWork W2094796405 @default.
- W2000432481 hasRelatedWork W2356152549 @default.
- W2000432481 hasRelatedWork W2381460883 @default.
- W2000432481 hasRelatedWork W2480785262 @default.
- W2000432481 hasRelatedWork W2807957985 @default.
- W2000432481 hasRelatedWork W3032772405 @default.
- W2000432481 hasRelatedWork W3094458952 @default.
- W2000432481 hasVolume "62" @default.
- W2000432481 isParatext "false" @default.
- W2000432481 isRetracted "false" @default.
- W2000432481 magId "2000432481" @default.
- W2000432481 workType "article" @default.